It's eyeforpharma Philadelphia's 15th year; already the largest, most senior and most influential forum for commercial pharma executives, but now in line for a reboot as we aim to position our industry ahead of the curve. Victory requires far more than just SFE, MCM and KAM - it means becoming the health partner of choice.
We, as patients, are becoming consumers. We're looking for value. We expect quality and real-time delivery. We are more than just empowered - we're in charge. 55+ Senior-level Speakers, 450+ attendee's all tackling the hard hitting theme's effecting commercial pharma. Find out more here.
- Kabir Nath, President & CEO, Otsuka North America
- Andy Schmeltz, Chief Commercial Officer, Pfizer Internal Medicine
- Sheldon Koenig, SVP and Global Head Cardiovascular Franchise, Sanofi
- Julie Gerberding, Executive VP & Chief Patient Office, Strategic Communications, Global Public Policy and Population Health, Merck
This is your opportunity to join the discussion with 2 days of expert presentations, interactive panels, keynote presentations and exclusive networking.
Join the most forward thinking speakers from across North America including C-level, VPs and industry leaders from Shire, Otsuka, GSK, Novartis, Pfizer, Google, Sanofi, Takeda and many more. This is the ideal place to ensure your commercial strategy is prepared for 2017 and beyond.
PharmaNews.eu readers can benefit from an exclusive discount - save $200 using our unique discount code WPN200 when you register online.
You can find full details of the meeting here.
Our mission is to make pharma more open and valued. The ultimate driver for the pharmaceutical industry's health is meeting the needs of patients, otherwise it will cease to matter. For healthcare to be as good as it could be, the strength, skills and resources of our industry need to be fully integrated into health outcomes and we need pharma experience at the decision-making table. We believe the industry must focus on a business model combining service with product, with patients at the center.